DK311683A - Fremgangsmaade til fremstilling af pyridylalkylnitratforbindelser - Google Patents

Fremgangsmaade til fremstilling af pyridylalkylnitratforbindelser Download PDF

Info

Publication number
DK311683A
DK311683A DK311683A DK311683A DK311683A DK 311683 A DK311683 A DK 311683A DK 311683 A DK311683 A DK 311683A DK 311683 A DK311683 A DK 311683A DK 311683 A DK311683 A DK 311683A
Authority
DK
Denmark
Prior art keywords
pyridylalkyl
preparation
procedure
nitrate compounds
alkyl
Prior art date
Application number
DK311683A
Other languages
Danish (da)
English (en)
Other versions
DK311683D0 (da
Inventor
Ikuo Ueda
Daizo Morino
Koichi Takimoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of DK311683D0 publication Critical patent/DK311683D0/da
Publication of DK311683A publication Critical patent/DK311683A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK311683A 1982-07-26 1983-07-05 Fremgangsmaade til fremstilling af pyridylalkylnitratforbindelser DK311683A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8221592 1982-07-26

Publications (2)

Publication Number Publication Date
DK311683D0 DK311683D0 (da) 1983-07-05
DK311683A true DK311683A (da) 1984-01-27

Family

ID=10531922

Family Applications (1)

Application Number Title Priority Date Filing Date
DK311683A DK311683A (da) 1982-07-26 1983-07-05 Fremgangsmaade til fremstilling af pyridylalkylnitratforbindelser

Country Status (17)

Country Link
US (2) US4540701A (ru)
EP (1) EP0100081B1 (ru)
JP (1) JPS5951263A (ru)
KR (1) KR900005470B1 (ru)
AT (1) ATE40948T1 (ru)
AU (1) AU565791B2 (ru)
CA (1) CA1216850A (ru)
DE (1) DE3379255D1 (ru)
DK (1) DK311683A (ru)
ES (1) ES524375A0 (ru)
FI (1) FI832490L (ru)
GR (1) GR78629B (ru)
HU (1) HU190497B (ru)
NO (1) NO832700L (ru)
PH (1) PH18083A (ru)
SU (1) SU1189337A3 (ru)
ZA (1) ZA835048B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6081166A (ja) * 1983-10-11 1985-05-09 Fujisawa Pharmaceut Co Ltd 2−ニトロオキシメチル−6−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
JPS6215A (ja) * 1985-02-26 1987-01-06 Fujisawa Pharmaceut Co Ltd 2−ニトロオキシメチル−6−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤
ZA885069B (en) * 1987-07-24 1989-03-29 Fujisawa Pharmaceutical Co Sustained-release percutaneous preparations
JPH02167279A (ja) * 1988-09-30 1990-06-27 Taisho Pharmaceut Co Ltd アポビンカミン酸誘導体
US5047543A (en) * 1988-11-24 1991-09-10 Taisho Pharmaceutical Co., Ltd. 1,4-dihydropyridine derivatives
CN106318877A (zh) * 2016-08-29 2017-01-11 刘翔 一种从茯砖茶中分离、纯化冠突散囊菌及其液态培养方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275642A (en) * 1962-04-26 1966-09-27 Bard Pharmaceutical Inc 3-pyridine carbinol nitrate and its preparation
US3689494A (en) * 1971-03-31 1972-09-05 William R J Simpson N-pyridinealkyl-alkanolamine nitrates

Also Published As

Publication number Publication date
JPS5951263A (ja) 1984-03-24
EP0100081A3 (en) 1985-05-02
CA1216850A (en) 1987-01-20
ZA835048B (en) 1984-03-28
SU1189337A3 (ru) 1985-10-30
PH18083A (en) 1985-03-18
HU190497B (en) 1986-09-29
ATE40948T1 (de) 1989-03-15
US4613608A (en) 1986-09-23
EP0100081A2 (en) 1984-02-08
JPS6350343B2 (ru) 1988-10-07
FI832490L (fi) 1984-01-27
EP0100081B1 (en) 1989-03-01
NO832700L (no) 1984-02-06
FI832490A0 (fi) 1983-07-07
ES8502088A1 (es) 1984-12-16
KR840005426A (ko) 1984-11-12
GR78629B (ru) 1984-09-27
US4540701A (en) 1985-09-10
AU1663583A (en) 1984-02-02
DK311683D0 (da) 1983-07-05
DE3379255D1 (en) 1989-04-06
ES524375A0 (es) 1984-12-16
AU565791B2 (en) 1987-10-01
KR900005470B1 (ko) 1990-07-30

Similar Documents

Publication Publication Date Title
FI850140A0 (fi) Kemiska foereningar.
ES8706664A1 (es) Procedimiento para preparar compuestos carbostirilicos
ES518227A0 (es) Procedimiento para preparar nuevos compuestos de cefem.
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
GR3001506T3 (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
ES8404360A1 (es) Un procedimiento para preparar compuestos de cefem.
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
DK311683A (da) Fremgangsmaade til fremstilling af pyridylalkylnitratforbindelser
DE3362876D1 (en) Dibenzocycloheptenylidene compounds for use in modulating the immune response
ES2060396T3 (es) Compuesto intermedio utilizado para la preparacion de deferoxamina.
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
ES8502094A1 (es) Un procedimiento para la preparacion de derivados de tetrahidroisoquinolina.
IL71430A (en) 2-imino-n-phenylsulfonyl-imidazolidine derivatives,process for the manufacture thereof and pharmaceutical preparations containing such compounds
DK84785A (da) Kinatsalte af antimalariaforbindelsen mefloquin
ES8504820A1 (es) Un procedimiento para preparar compuestos de cefem que tienen grupos tiadiazol c isotiazol.
JPS5285156A (en) 2-(omega-aminoalkoxy)diphenylmethylmethanes

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment